Art

J-GLOBAL ID：202102286737521470   Reference number：21A2265313

Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence

オキサリプラチン誘発末梢神経障害の治療剤;実験的および臨床的エビデンス【JST・京大機械翻訳】

Author (8)： Kawashiri Takehiro (Department of Clinical Pharmacy and Pharmaceutical Care, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan) ,  Mine Keisuke (Department of Clinical Pharmacy and Pharmaceutical Care, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan) ,  Kobayashi Daisuke (Department of Clinical Pharmacy and Pharmaceutical Care, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan) ,  Inoue Mizuki (Department of Clinical Pharmacy and Pharmaceutical Care, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan) ,  Ushio Soichiro (Department of Pharmacy, Okayama University Hospital, Okayama 700-8558, Japan) ,  Uchida Mayako (Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, Osaka 569-1094, Japan) ,  Egashira Nobuaki (Department of Pharmacy, Kyushu University Hospital, Fukuoka 812-8582, Japan) ,  Shimazoe Takao (Department of Clinical Pharmacy and Pharmaceutical Care, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan)
Material： International Journal of Molecular Sciences (Web)  (Int J Mol Sci (Web))
Volume： 22  Issue： 3  Page： 1393  Publication year： 2021 
JST Material Number： U7038A  ISSN： 1422-0067  CODEN： IJMCFK  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Oxaliplatin is an essential dr...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A2265313&from=J-GLOBAL&jstjournalNo=U7038A") }}

Thesaurus term： electric potential ,  nervous system ,  receptor ,  side effect ,  drug therapy ,  clinical trial ,  sodium channel ,  pancreatic tumor ,  *neuropathy ,  oxidative stress ,  amino acid ,  aliphatic amine ,  aliphatic carboxylic acid ,  dicarboxylic acid ,  primary amine
Semi thesaurus term： 動物モデル ,  モノアミン ,  *オキサリプラチン ,  臨床研究 , 【Automatic Indexing@JST】

Author keywords (5)： oxaliplatin ,  peripheral neuropathy ,  preclinical data ,  clinical evidence ,  adverse effects

JST classification (4)： Digestive system diseases  (GH03000W) ,  Treatment for nervous system diseases in general  (GN05010N) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Nervous system diseases  (GN03000O)

Substance index (1)： Glutamic acid

Reference (162)：

• Wilson, R.H.; Lehky, T.; Thomas, R.R.; Quinn, M.G.; Floeter, M.K.; Grem, J.L. Acute oxaliplatin-induced peripheral nerve hyperexcitability. J. Clin. Oncol. 2002, 20, 1767-1774.
• Argyriou, A.A.; Bruna, J.; Marmiroli, P.; Cavaletti, G. Chemotherapy-induced peripheral neurotoxicity (CIPN): An update. Crit. Rev. Oncol. Hematol. 2012, 82, 51-77.
• Pasetto, L.M.; D’Andrea, M.R.; Rossi, E.; Monfardini, S. Oxaliplatin-related neurotoxicity: How and why? Crit. Rev Oncol. Hematol. 2006, 59, 159-168.
• Sittl, R.; Lampert, A.; Huth, T.; Schuy, E.T.; Link, A.S.; Fleckenstein, J.; Alzheimer, C.; Grafe, P.; Carr, R.W. Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent current. Proc. Natl. Acad. Sci. USA 2012, 24, 6704-6709.
• Kagiava, A.; Tsingotjidou, A.; Emmanouilides, C.; Theophilidis, G. The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat. Neurotoxicology 2008, 29, 1100-1106.

Terms in the title (7)： オキサリプラチン ,  誘発 ,  末梢神経障害 ,  治療 ,  実験 ,  臨床 ,  エビデンス